Fate Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Fate Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Fate Therapeutics Inc Strategy Report
- Understand Fate Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Fate Therapeutics Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Fate Therapeutics Insights data
Headline | Published | Journalists |
---|---|---|
Deserunt mollit sunt Lorem laborum do id aliqua dolore | 09 Oct 2020 | Lorem |
Fate’s multitargeted CAR NK carries potential to avoid antigen escape challenge; earlier intervention holds potential, experts say | 08 Oct 2020 | Manasi Vaidya |
Innate Pharma recruits about 30 of 40 patients in second cohort of Phase Ib/II monalizumab trial in head and neck cancer, to close in the summer, source says | 04 Jun 2019 | Reynald Castaneda |
Fate Therapeutics’ NK cell cancer immunotherapy NK100 yet to convince on early efficacy data; intraperitoneal route finds support for ovarian cancer while future combo likely, experts say | 16 Oct 2018 | Manasi Vaidya |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward